保诚金融公司削减了1Life Healthcare, Inc.（纳斯达克股票代码：ONEM）的头寸

Prudential Financial Inc. trimmed its position in shares of 1Life Healthcare, Inc. (NASDAQ:ONEM – Get Rating) by 73.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,785 shares of the company's stock after selling 35,850 shares during the period. Prudential Financial Inc.'s holdings in 1Life Healthcare were worth $219,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. Raymond James & Associates acquired a new stake in shares of 1Life Healthcare in the first quarter valued at approximately $120,000. US Bancorp DE raised its position in 1Life Healthcare by 88.8% in the first quarter. US Bancorp DE now owns 4,492 shares of the company's stock worth $50,000 after acquiring an additional 2,113 shares in the last quarter. MetLife Investment Management LLC raised its position in 1Life Healthcare by 58.5% in the first quarter. MetLife Investment Management LLC now owns 66,199 shares of the company's stock worth $733,000 after acquiring an additional 24,432 shares in the last quarter. Rhumbline Advisers raised its position in 1Life Healthcare by 2.8% in the first quarter. Rhumbline Advisers now owns 127,469 shares of the company's stock worth $1,412,000 after acquiring an additional 3,448 shares in the last quarter. Finally, Great West Life Assurance Co. Can increased its position in shares of 1Life Healthcare by 76.5% in the first quarter. Great West Life Assurance Co. Can now owns 8,181 shares of the company's stock valued at $96,000 after buying an additional 3,547 shares in the last quarter. 78.20% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at 1Life Healthcare

In related news, CFO Bjorn B. Thaler sold 6,015 shares of the firm's stock in a transaction on Thursday, February 16th. The stock was sold at an average price of $15.36, for a total transaction of $92,390.40. Following the completion of the sale, the chief financial officer now directly owns 21,532 shares of the company's stock, valued at approximately $330,731.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, General Counsel Lisa A. Mango sold 7,596 shares of the firm's stock in a transaction on Thursday, February 16th. The stock was sold at an average price of $15.36, for a total value of $116,674.56. Following the transaction, the general counsel now directly owns 94,535 shares in the company, valued at approximately $1,452,057.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Bjorn B. Thaler sold 6,015 shares of 1Life Healthcare stock in a transaction dated Thursday, February 16th. The stock was sold at an average price of $15.36, for a total value of $92,390.40. Following the transaction, the chief financial officer now owns 21,532 shares in the company, valued at $330,731.52. The disclosure for this sale can be found here. Insiders sold a total of 22,044 shares of company stock valued at $347,242 in the last quarter. Corporate insiders own 4.40% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Credit Suisse Group cut 1Life Healthcare from an "outperform" rating to a "neutral" rating and set a $18.00 price objective for the company. in a research report on Thursday, October 27th. Thirteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, 1Life Healthcare currently has an average rating of "Hold" and an average target price of $16.50.

1Life Healthcare Price Performance

Shares of NASDAQ:ONEM opened at $16.01 on Friday. The business has a 50 day moving average price of $16.21 and a 200 day moving average price of $16.75. 1Life Healthcare, Inc. has a twelve month low of $5.94 and a twelve month high of $17.55. The company has a market cap of $3.27 billion, a price-to-earnings ratio of -7.93 and a beta of 1.99. The company has a quick ratio of 2.06, a current ratio of 2.09 and a debt-to-equity ratio of 0.20.

About 1Life Healthcare

(Get Rating)

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.

Featured Articles

• Get a free copy of the StockNews.com research report on 1Life Healthcare (ONEM)
• MarketBeat Week in Review – 2/13 – 2/17
• Deere Stock Raises Outlook and is Ready to Power Higher
• DraftKings Crowning Achievement: Leverage
• Tesla Stock Comeback Is Picking Up Steam
• How Abbott Labs, AbbVie Could Profit on Seizure Drug Formula

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.